Quant ScoreQuant Score (0–100) is a weighted blend of risk-adjusted metrics: Sharpe 20 · Sortino 20 · Max Drawdown 15 · Annual Return 10 · Volatility 10, plus (when available) Calmar · Omega · Beta.
Sharpe & Sortino use an S-curve (logistic) scale — the difference between a Sharpe of 1 and 2 matters more than 5 vs 6. Weights are normalized so a metric that's temporarily missing is scored neutral instead of silently rescaling the others.
33/100
Weak
Sharpe Ratio3.6/18.2
Sortino Ratio3.3/18.2
Excess Drawdown vs SPY0/13.6
Annual Return7.4/9.1
Volatility1.8/9.1
Calmar Ratio4.6/9.1
Omega Ratio3.9/9.1
Beta3.7/4.5
Momentum (12-1)5.1/9.1
Period Returns
1m Return
-4.35%
↺
1m Return
Recent 1-month price change. Short-term momentum signal — a useful gauge of whether the stock has had recent strength or weakness heading into the current session.
↺
3m Return
+0.99%
↺
3m Return
3-month price change, a core window in factor models. Positive 3m momentum with improving fundamentals is a classic setup for continued outperformance.
↺
6m Return
+61.03%
↺
6m Return
6-month price change. Research (Jegadeesh & Titman) shows 6–12 month returns have predictive power — stocks in the top decile tend to outperform over the next quarter.
↺
1y Return
+11.44%
↺
1y Return
12-month price change. Year-over-year return anchors relative strength comparisons and is the primary window used in momentum indices and most factor-based screens.
↺
Price Z-Score
20d Window
-1.61
Notable deviation
↺
20d Z-Score
How many standard deviations the current price sits above or below its 20-day moving average. Readings beyond ±2 are statistically unusual and often precede a mean-reversion move.
↺
50d Window
-1.17
Notable deviation
↺
50d Z-Score
Same measure over a 50-day window. Slower-moving and less noisy than the 20d. Extreme ±2σ readings on the 50d are rarer, tend to carry more weight, and suit swing or position traders.
↺
Risk Metrics
Ann. Return
+20.65%
↺
Ann. Return
Compound annual growth rate derived from the past year of daily returns. Comparable across stocks regardless of holding period.
↺
Ann. Volatility
49.85%
↺
Ann. Volatility
Annualized standard deviation of daily returns. Higher volatility means wider expected daily swings — divide by ~16 to estimate the one-day expected move.
↺
Vol Regime
High
↺
Vol Regime
Classifies current volatility vs the stock's own history. High/Elevated regimes suit options strategies or tighter stops; Low regimes favor trend-following entries.
↺
Beta vs SPY
1.38
↺
Beta vs SPY
Sensitivity to S&P 500 moves. A beta of 1.5 means the stock tends to move 1.5× the market in either direction. Use to size positions and estimate market exposure.
↺
Corr. vs SPY
0.47
↺
Corr. vs SPY
Pearson correlation with SPY over the past year. Near 1.0 = moves in lockstep with the market. Lower values indicate more independent price action, useful for diversification.
↺
Sharpe Ratio
0.29
↺
↺
iRepligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
Sharpe Ratio
Risk-adjusted return: annualized excess return divided by annualized volatility. Above 1.0 is good; above 2.0 is exceptional. Negative means underperforming cash on a risk basis.
Sortino Ratio
0.45
↺
Sortino Ratio
Like Sharpe, but only penalises downside volatility — upside swings aren't counted against the stock. Preferred when gains are asymmetric. Above 1.5 is considered strong.
↺
Max Drawdown
-41.0%
↺
Max Drawdown
Largest peak-to-trough decline over the past year. Represents the worst-case loss for an investor who bought at the top. Critical input for position sizing and stop-loss placement.
↺
Calmar Ratio
0.50
↺
Calmar Ratio
Annualized return divided by maximum drawdown. A Calmar above 1.0 means the stock earns more per year than its worst historical drawdown — a useful risk/reward summary.